Summary

Ceres Nanosciences , Inc.

Founded in 2008

Description

Ceres Nanosciences provides a novel sample preparation tool for a wide range of diagnostic applications and sample handling needs. One Step Purification, Preservation, Concentration, of the most valuable biomarkers, from any sample type, for the most r...

Strengths

  • Ceres Nanosciences , Inc. has a strong market share in their industry
  • Demonstrating revenue growth that is faster than the industry average
  • The number of employees is growing faster than the industry average
  • Since Ceres Nanosciences , Inc. was founded, the company has grown faster than the industry average
  • Employees are staying with the company and less likely to churn compared to the rest of the industry

Weaknesses

  • Revenue generated per employee is less than the industry average
  • Variance of revenue growth is more than the industry average

Annual Revenue

Ceres Nanosciences , Inc.'s annual revenue

$4088000

Based on Kona Equity data

  • Revenue per employee

    $240471

  • Variance of revenue growth

    1.93

  • Annual revenue growth since founding

    $255500

  • Revenue growth rate from first known quarter to current

    77.9%

Employee Count

17 employees

  • Employee growth rate from first known quarter to current

    84.6%

  • Current employees on Linkedin

    29

  • Churned employees

    19

  • Churn rate percentage

    65.52%

Executives

Ross Dunlap

Chief Executive Officer & Co-Founder, A

r**@ceresnano.com

Chamodya Ruhunusiri

Research Assistant

c**@ceresnano.com

Benjamin Lepene

Chief Technology Officer

b**@ceresnano.com

Ketul Shah

Manager, Product Development

k**@ceresnano.com

Tara Jones-Roe

Vice President, Sales & Marketing

t**@ceresnano.com

Sayed Mosavi

Chemical Hygiene Officer

s**@ceresnano.com

Emily Milich

Sales Specialist

e**@ceresnano.com

Robbie Barbero

Chief Business Officer

r**@ceresnano.com

Anurag Patnaik

Director, Manufacturing Operations

a**@ceresnano.com

Robert Barclay

Senior Scientist

r**@ceresnano.com

Sophia Bellakbira

Associate Scientist

s**@ceresnano.com

Laura Sweet

Production Technician

l**@ceresnano.com

Kevin Kolb

Quality Engineer

k**@ceresnano.com

Phone Nanosciences

Chief Executive Officer

p**@ceresnano.com

G Score - 5

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G1 Revenue is greater than the industry median.
  • G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
  • G4 Employee growth rate from the first known quarter to current is higher than the industry average.
  • G6 Annual revenue growth since founding is higher than the industry average.
  • G8 LinkedIn Churn is lower than the industry average.

Location

9460 Innovation Dr. 
Manassas, VA  20110

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Similar Companies

Ambergen

ambergen.com
  • Founded in 1993
  • Location: Watertown, MA
  • Annual Revenue: $3.3M
  • Employees: 13
  • Ambergen is a privately held biotechnology company that is developing a new generation of diagnostic tests. They are transforming spatial biology with the power of mass spectrometry, offering multiplex, multiomic, multimodal, and whole slide imaging ca...

Biosan

biosan.lv
  • Founded in 1992
  • Location: Riga, None
  • Annual Revenue: $13.9M
  • Employees: 31
  • The company BIOSAN SIA is a leading provider of innovative laboratory instruments for sample preparation in the field of genomics, proteomics, and cellomics. With over 24 years of experience, BIOSAN SIA has developed a range of personal compact, multif...

DPX Technologies LLC

dpxtechnologies.com
  • Founded in 2007
  • Location: Columbia, SC
  • Annual Revenue: $3.9M
  • Employees: 17
  • INTip solutions for solid phase extraction and filtration. Pipette tips are easy to use and easy to automate.

American Biogenetic Sciences Inc

mabxa.com
  • Founded in 1983
  • Location: Copiague, NY
  • Annual Revenue: $6.3M
  • Employees: 28
  • USA Equities Corp., formerly American Biogenetic Sciences, Inc., is a shell company. The Company focuses to seek new business opportunities, including seeking an acquisition or merger with an operating company. The Company's subsidiary, USA Equities Trust, Inc., is engaged in acquiring real estate. The Company was eng…

Metabolomic Technologies

mtidx.com
  • Founded in 2010
  • Location: Edmonton, Alberta
  • Annual Revenue: $4.9M
  • Employees: 25
  • Metabolomic Technologies Inc. is a company developing metabolomics based in vitro diagnostics for cancer and other diseases. Our lead product is PolypDx, a urine-based screening test for the detection of adenomatous polyps and colorectal cancer. We sp...

Cellmid

anagenics.com
  • Founded in 2004
  • Location: Sydney, New South Wales
  • Annual Revenue: $5.4M
  • Employees: 72

Key Information

  • SIC: 80; 8071
  • NAICS: 5417; 541
Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with Ceres Nanosciences , Inc..

See similar companies

Frequently Asked Questions

Where is Ceres Nanosciences , Inc. located?

Ceres Nanosciences , Inc.'s headquarters are located at 9460 Innovation Dr.  Manassas, VA  20110.


What is Ceres Nanosciences , Inc.'s official website?

Ceres Nanosciences , Inc.'s official website is ceresnano.com


What is Ceres Nanosciences , Inc.'s revenue?

Ceres Nanosciences , Inc.'s annual revenue is $4.1 M.


What is Ceres Nanosciences , Inc.'s SIC code?

Ceres Nanosciences , Inc.'s SIC: 80; 8071


What is Ceres Nanosciences , Inc.'s NAICS code?

Ceres Nanosciences , Inc.'s NAICS: 5417; 541.


How many employees does Ceres Nanosciences , Inc.'s have?

Ceres Nanosciences , Inc. has 17 employees


What industry does Ceres Nanosciences , Inc. belong to?

Ceres Nanosciences , Inc. is in the industry of Pharmaceuticals.

Next step

Visitors review